KFG Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$872K Sell
4,142
-18
-0.4% -$3.61K 0.09% 92
2026
Q2
$791K Buy
4,160
+398
+11% +$68.4K 0.09% 102
2026
Q1
$635K Buy
3,762
+282
+8% +$48.2K 0.08% 109
2025
Q4
$587K Buy
3,480
+533
+18% +$86.6K 0.08% 117
2025
Q3
$425K Buy
2,947
+503
+21% +$68.7K 0.06% 142
2025
Q2
$309K Buy
2,444
+112
+5% +$13.7K 0.05% 164
2025
Q1
$298K Buy
2,332
+189
+9% +$25.6K 0.05% 156
2024
Q4
$283K Buy
2,143
+168
+9% +$23.6K 0.05% 154
2024
Q3
$288K Buy
1,975
+415
+27% +$60K 0.06% 146
2024
Q2
$214K Buy
+1,560
New +$208K 0.08% 153
2023
Q1
– Sell
-68,480
Closed -$8.99M – 96
2022
Q4
$8.99M Buy
+68,480
New +$8.85M 9.21% 4

Other funds holding IBB

KFG Wealth Management's IBB Position: Q3 2026 in Review

KFG Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 0.43% in Q3 2026, selling an estimated $3.61K and leaving 4,142 shares worth $872K. The position accounts for 0.09% of the portfolio, ranked #92.

KFG Wealth Management first reported a position in IBB in Q4 2022 and has held it in 11 quarters since. The position peaked at $8.99M in Q4 2022. 303 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • KFG Wealth Management held 4,142 shares of iShares Biotechnology ETF worth $872K as of Q3 2026.
  • KFG Wealth Management sold 18 iShares Biotechnology ETF shares in Q3 2026, an estimated $3.61K.
  • iShares Biotechnology ETF made up 0.09% of KFG Wealth Management's portfolio in Q3 2026, its #92 holding.
  • KFG Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 11 quarters since.
  • KFG Wealth Management's iShares Biotechnology ETF position peaked at $8.99M in Q4 2022.
  • 303 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on KFG Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.